Literature DB >> 16997754

Activity-dependent modulation of inhibition in Purkinje cells by TrkB ligands.

Rosemarie Drake-Baumann1.   

Abstract

In the cerebellum in vitro TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis of Purkinje cells and also modulate inhibitory synaptic function. This mini review examines the roles of TrkB receptor activation by BDNF particularly in relation to activity-dependent synaptic plasticity on Purkinje cells and recent studies on the acute modulation of GABAergic synapses by BDNF.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16997754     DOI： 10.1080/14734220600621344

Source DB:  PubMed          Journal:  Cerebellum        ISSN： 1473-4222            Impact factor:   3.847


  52 in total

1.  BDNF and NT-4, but not NT-3, promote development of inhibitory synapses in the absence of neuronal activity.

Authors:  F J Seil
Journal:  Brain Res       Date:  1999-02-13       Impact factor: 3.252

Review 2.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 3.  Neurotrophins and neuronal differentiation in the central nervous system.

Authors:  A K McAllister
Journal:  Cell Mol Life Sci       Date:  2001-07       Impact factor: 9.261

4.  Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus.

Authors:  M Frerking; R C Malenka; R A Nicoll
Journal:  J Neurophysiol       Date:  1998-12       Impact factor: 2.714

Review 5.  Neurotrophins and activity-dependent development of the neocortex.

Authors:  T Bonhoeffer
Journal:  Curr Opin Neurobiol       Date:  1996-02       Impact factor: 6.627

6.  Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons.

Authors:  L J Goodman; J Valverde; F Lim; M D Geschwind; H J Federoff; A I Geller; F Hefti
Journal:  Mol Cell Neurosci       Date:  1996-03       Impact factor: 4.314

7.  Characterization of the responses of Purkinje cells to neurotrophin treatment.

Authors:  L Lärkfors; R M Lindsay; R F Alderson
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

8.  TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis.

Authors:  F J Seil; R Drake-Baumann
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

9.  Phenotype of cerebellar glutamatergic neurons is altered in stargazer mutant mice lacking brain-derived neurotrophic factor mRNA expression.

Authors:  Christine A Richardson; Beulah Leitch
Journal:  J Comp Neurol       Date:  2005-01-10       Impact factor: 3.215

Review 10.  Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS.

Authors:  V Lessmann
Journal:  Gen Pharmacol       Date:  1998-11
View more
  4 in total

1.  Dissociating the roles of the cerebellum and motor cortex during adaptive learning: the motor cortex retains what the cerebellum learns.

Authors:  Joseph M Galea; Alejandro Vazquez; Neel Pasricha; Jean-Jacques Orban de Xivry; Pablo Celnik
Journal:  Cereb Cortex       Date:  2010-12-07       Impact factor: 5.357

2.  Preoperative anxiety-induced glucocorticoid signaling reduces GABAergic markers in spinal cord and promotes postoperative hyperalgesia by affecting neuronal PAS domain protein 4.

Authors:  Hao Wu; Yulin Huang; Xinyu Tian; Zuoxia Zhang; Ying Zhang; Yanting Mao; Chenchen Wang; Shuai Yang; Yue Liu; Wei Zhang; Zhengliang Ma
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

3.  Effect and mechanism of BDNF/TrkB signaling on vestibular compensation.

Authors:  Dehong Mao; Zhongmei He; Wei Xuan; Jiao Deng; Weichun Li; Xiaoying Fang; Linglong Li; Feng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  Synapse elimination in the developing cerebellum.

Authors:  Kouichi Hashimoto; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2013-06-28       Impact factor: 9.261
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.